ICR Westwicke is an IPO advisory, capital markets advisory, and strategic communications firm. We provide integrated investor relations, public relations, and independent capital markets advice to small and mid-cap healthcare companies.
We work with private and public healthcare companies to help position their story properly with all critical stakeholders and to develop value-added strategies to build brand awareness, corporate reputation and enhance equity market value. Through an integrated approach, we provide a one-stop-shop for the full spectrum of communications needs across the entire corporate lifecycle from early stage start-up to mature public company.
Our background is unique. Our investor relations partners all come directly from Wall Street as former sell-side research analysts, institutional salesmen, investment bankers, equity capital markets professionals, buy-side analysts and portfolio managers, while our public relations team are former agency veterans, corporate communications executives and journalists.
Learn more
Latest Blog Posts
-
November 14th, 2022
Best Practices for Earnings Call Preparation
Engaging consistently with these core elements for earnings call preparation will provide a foundation for a record of successful earnings conference calls.
-
October 25th, 2022
Biotech Investment Trends: Perspectives from the Sell Side
After a significant biotech boom over the last few years, the market has quieted. What does that mean for companies that want to pursue an IPO, and what are banks and analysts looking for in potential investments? To gain perspective on the current biotech investment landscape and sector outlook, ICR Westwicke recently hosted a webinar, […]
-
September 26th, 2022
The ‘Innovator’s Burden’: How to combat skepticism in healthcare as a first-of-its-kind company
From new treatments and technologies to platforms and diagnostics, we may be living through the greatest period of innovation in the history of healthcare. The biopharma industry’s efforts to rapidly develop multiple safe and efficacious life-saving vaccines for the Covid-19 pandemic is just the latest example of the collective appreciation for innovation and its ability […]
